Safety and Efficacy Study of RX-10045 on the Signs and Symptoms of Dry Eye

NCT00799552 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

232

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye Syndrome

Interventions

DRUG: RX-10045
DRUG: Placebo

Sponsor

Resolvyx Pharmaceuticals, Inc